Literature DB >> 23354097

Phosphorylation of IGFBP-1 at discrete sites elicits variable effects on IGF-I receptor autophosphorylation.

Majida Abu Shehab1, Cristiana Iosef, Robert Wildgruber, Girish Sardana, Madhulika B Gupta.   

Abstract

We previously demonstrated that hypoxia and leucine deprivation cause hyperphosphorylation of IGF-binding protein-1 (IGFBP-1) at discrete sites that markedly enhanced IGF-I affinity and inhibited IGF-I-stimulated cell growth. In this study we investigated the functional role of these phosphorylation sites using mutagenesis. We created three IGFBP-1 mutants in which individual serine (S119/S169/S98) residues were substituted with alanine and S101A was recreated for comparison. The wild-type (WT) and mutant IGFBP-1 were expressed in Chinese hamster ovary cells and IGFBP-1 in cell media was isolated using isoelectric-focusing-free-flow electrophoresis. BIACore analysis indicated that the changes in IGF-I affinity for S98A and S169A were moderate, whereas S119A greatly reduced the affinity of IGFBP-1 for IGF-I (100-fold, P < .0001). Similar results were obtained with S101A. The IGF-I affinity changes of the mutants were reflected in their ability to inhibit IGF-I-induced receptor autophosphorylation. Employing receptor-stimulation assay using IGF-IR-overexpressing P6 cells, we found that WT-IGFBP-1 inhibited IGF-IRβ autophosphorylation (~2-fold, P < .001), possibly attributable to sequestration of IGF-I. Relative to WT, S98A and S169A mutants did not inhibit receptor autophosphorylation. S119A, on the other hand, greatly stimulated the receptor (2.3-fold, P < .05). The data with S101A matched S119A. In summary, we show that phosphorylation at S98 and S169 resulted in milder changes in IGF-I action; nonetheless most dramatic inhibitory effects on the biological activity of IGF-I were due to IGFBP-1 phosphorylation at S119. Our results provide novel demonstration that IGFBP-1 phosphorylation at S119 can enhance affinity for IGF-I possibly through stabilization of the IGF-IGFBP-1 complex. These data also propose that the synergistic interaction of distinct phosphorylation sites may be important in eliciting more pronounced effects on IGF-I affinity that needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354097     DOI: 10.1210/en.2012-1962

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  Hyperphosphorylation of fetal liver IGFBP-1 precedes slowing of fetal growth in nutrient-restricted baboons and may be a mechanism underlying IUGR.

Authors:  Jenica H Kakadia; Bhawani B Jain; Kyle Biggar; Austen Sutherland; Karen Nygard; Cun Li; Peter W Nathanielsz; Thomas Jansson; Madhulika B Gupta
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-08-03       Impact factor: 4.310

2.  The role and regulation of IGFBP-1 phosphorylation in fetal growth restriction.

Authors:  Madhulika B Gupta
Journal:  J Cell Commun Signal       Date:  2015-02-15       Impact factor: 5.782

3.  Hypoxia Increases IGFBP-1 Phosphorylation Mediated by mTOR Inhibition.

Authors:  Ian Damerill; Kyle K Biggar; Majida Abu Shehab; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Endocrinol       Date:  2015-12-29

Review 4.  Novel roles of mechanistic target of rapamycin signaling in regulating fetal growth†.

Authors:  Madhulika B Gupta; Thomas Jansson
Journal:  Biol Reprod       Date:  2019-04-01       Impact factor: 4.285

5.  IUGR Is Associated With Marked Hyperphosphorylation of Decidual and Maternal Plasma IGFBP-1.

Authors:  Madhulika B Gupta; Majida Abu Shehab; Karen Nygard; Kyle Biggar; Sahil S Singal; Nanette Santoro; Theresa L Powell; Thomas Jansson
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

6.  Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction.

Authors:  Majida Abu Shehab; Ian Damerill; Tong Shen; Fredrick J Rosario; Mark Nijland; Peter W Nathanielsz; Amrita Kamat; Thomas Jansson; Madhulika B Gupta
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

7.  Exposure of decidualized HIESC to low oxygen tension and leucine deprivation results in increased IGFBP-1 phosphorylation and reduced IGF-I bioactivity.

Authors:  Majida Abu Shehab; Kyle Biggar; Sahil Sagar Singal; Karen Nygard; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Cell Endocrinol       Date:  2017-04-21       Impact factor: 4.102

8.  Increased IGFBP-1 phosphorylation in response to leucine deprivation is mediated by CK2 and PKC.

Authors:  Niyati Malkani; Kyle Biggar; Majida Abu Shehab; Shawn Shun-Cheng Li; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Cell Endocrinol       Date:  2015-12-28       Impact factor: 4.102

Review 9.  IGF binding proteins in cancer: mechanistic and clinical insights.

Authors:  Robert C Baxter
Journal:  Nat Rev Cancer       Date:  2014-04-10       Impact factor: 60.716

10.  IGFBP-1 hyperphosphorylation in response to leucine deprivation is mediated by the AAR pathway.

Authors:  Niyati Malkani; Thomas Jansson; Madhulika B Gupta
Journal:  Mol Cell Endocrinol       Date:  2015-05-05       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.